Enables direct brain access by bypassing the blood-brain barrier (BBB).
Achieves therapeutic effects with significantly lower dosages.
Minimizes toxicity and drug-drug interactions while enhancing safety profiles.
Non-invasive delivery increases compliance and supports use in acute field settings and home care management.
Proprietary airflow system delivers high-velocity, rifled drug dispersion for precise nasal targeting.
Enables direct and rapid drug transport to the brain within minutes via neural and vascular pathways.
Temperature-stable spray-dried powders enhance absorption through the nasal lining for optimized neurological efficacy.
Superior tolerability compared to other routes, avoiding common side effects like nausea, fatigue & more